tiprankstipranks

James Campbell Insider Profile

4 Followers
James Campbell, Director at Prescient Therapeutics Limited, holds 396.37K shares in Prescient Therapeutics Limited (Ticker: AU:PTX).
tipranks
James  Campbell

James Campbell
Prescient Therapeutics Limited (PTX)
Director

Ranked #85,348 out of 99,797 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-58.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

AU$17K
100.00%
A breakdown of James Campbell's holdings

Insider Roles

Prescient Therapeutics Limited
(PTX)
Director
Roles that James Campbell holds in companies

Most Profitable Insider Trade

Stock:
Prescient Therapeutics Limited
(PTX)
Rating:Informative Buy
Date:Mar 26, 2019 - Mar 26, 2020
Return:-50.90%
The most profitable trade made by James Campbell

James Campbell's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Prescient Therapeutics Limited
May 02, 2023
Director
Uninformative Sell
AU$16.65K
Success Rate for
PTX
0 out of 2 profitable transactions on
PTX
0%
Average Return for
PTX
Average return per transaction on
PTX
-58.50%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Mar 26, 2019
Informative Buy
AU$9.97K
-
AU$0.06
-50.90%
Oct 12, 2022
Informative Buy
AU$5.00K
-
AU$0.18
-66.10%
Apr 04, 2023
Uninformative Sell
AU$1.11K
-
AU$0.06
May 02, 2023
Uninformative Sell
AU$0.00
-
AU$0.00
List of latest transactions for each holding click on a transaction to see James Campbell's performance on stock

James Campbell insider profile FAQ

What is the percentage of profitable transactions made by James Campbell?
The percentage of profitable transactions made by James Campbell is 0%.
    What is the average return per transaction made by James Campbell?
    The average return per transaction made by James Campbell is -58.50%.
      What stocks does James Campbell hold?
      James Campbell holds: AU:PTX stocks.
        What was James Campbell’s latest transaction?
        James Campbell latest transaction was an Uninformative Sell of ―.
          What was James Campbell's most profitable transaction?
          James Campbell’s most profitable transaction was an Informative Buy of AU:PTX stock on March 26, 2019. The return on the trade was -50.90%.
            What is James Campbell's role in Prescient Therapeutics Limited?
            James Campbell's role in Prescient Therapeutics Limited is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.